We are live on
!
Find out more
BCM
Bayesian Capital Management Portfolio holdings
AUM
$81.9M
1-Year Est. Return
26.59%
This Fund
S&P 500
This Quarter
Est. Return
-0.68%
1 Year Est. Return
+26.59%
3 Year Est. Return
+112.98%
5 Year Est. Return
+129.77%
10 Year Est. Return
+1,146.62%
AUM
$604M
AUM Growth
-$213M
(-26%)
Cap. Flow
-$186M
Cap. Flow
% of AUM
-30.79%
Top 10 Holdings %
Top 10 Hldgs %
13.62%
Holding
1,036
New
389
Increased
70
Reduced
105
Closed
470
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Cisco
CSCO
|
+$12.4M |
| 2 |
Advanced Micro Devices
AMD
|
+$10.8M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$9.35M |
| 4 |
Workday
WDAY
|
+$7.63M |
| 5 |
Coca-Cola
KO
|
+$7.56M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Nike
NKE
|
+$15.4M |
| 2 |
Amgen
AMGN
|
+$11.2M |
| 3 |
Salesforce
CRM
|
+$9.62M |
| 4 |
Danaher
DHR
|
+$9.18M |
| 5 |
Union Pacific
UNP
|
+$8.98M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.33% |
| 2 | Consumer Discretionary | 16.35% |
| 3 | Healthcare | 12.02% |
| 4 | Industrials | 10.05% |
| 5 | Consumer Staples | 8.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
501
Caleres
CAL
$432M
| $190K | 0.03% |
+11,010
| New | +$198K |
|
502
Sotera Health
SHC
$5B
| $182K | 0.03% |
+15,641
| New | +$201K |
|
|
ACB
503
Aurora Cannabis
ACB
$169M
| $182K | 0.03% |
+41,501
| New | +$196K |
|
504
Expro Ltd
XPRO
$1.66B
| $178K | 0.03% |
+17,893
| New | +$221K |
|
505
Iris Energy
IREN
$10.5B
| $175K | 0.03% |
+28,800
| New | +$280K |
|
506
DNOW Inc
DNOW
$2.44B
| $175K | 0.03% |
10,262
+224
| +2% | +$3.39K |
|
507
Newmark Group
NMRK
$2.64B
| $173K | 0.03% |
+14,200
| New | +$189K |
|
508
Dyne Therapeutics
DYN
$4.15B
| $172K | 0.03% |
+16,400
| New | +$235K |
|
509
Digital Turbine
APPS
$982M
| $169K | 0.03% |
+62,368
| New | +$202K |
|
510
Douglas Emmett
DEI
$2.05B
| $166K | 0.03% |
+10,400
| New | +$176K |
|
511
Arrowhead Research
ARWR
$12.1B
| $166K | 0.03% |
+13,000
| New | +$236K |
|
512
Pebblebrook Hotel Trust
PEB
$2.18B
| $163K | 0.03% |
+16,065
| New | +$197K |
|
|
SERV
513
Serve Robotics
SERV
$372M
| $163K | 0.03% |
+28,271
| New | +$371K |
|
|
FOLD
514
DELISTED
Amicus Therapeutics
FOLD
| $162K | 0.03% |
19,900
-47,000
| -70% | -$435K |
|
515
Janus International
JBI
$702M
| $160K | 0.03% |
+22,201
| New | +$176K |
|
516
Leggett & Platt
LEG
$1.4B
| $160K | 0.03% |
+20,166
| New | +$191K |
|
517
Gray Television
GTN
$437M
| $156K | 0.03% |
+36,100
| New | +$142K |
|
518
Banco Santander
SAN
$191B
| $153K | 0.03% |
+22,900
| New | +$134K |
|
|
HSAI
519
Hesai Group
HSAI
$2.57B
| $153K | 0.03% |
+10,363
| New | +$177K |
|
520
Bausch Health
BHC
$1.75B
| $147K | 0.02% |
+22,700
| New | +$163K |
|
|
DAWN
521
DELISTED
Day One Biopharmaceuticals
DAWN
| $143K | 0.02% |
+18,000
| New | +$194K |
|
522
Nu Skin
NUS
$257M
| $141K | 0.02% |
+19,402
| New | +$141K |
|
523
Denali Therapeutics
DNLI
$3.79B
| $138K | 0.02% |
10,130
-8,690
| -46% | -$167K |
|
524
Rocket Pharmaceuticals
RCKT
$343M
| $137K | 0.02% |
20,536
-9,000
| -30% | -$88.9K |
|
525
Coursera
COUR
$1.77B
| $136K | 0.02% |
+20,358
| New | +$162K |
|
Similar funds
KL
FWS
AGFVA
1C
MP
FLC
APW
QM
Bayesian Capital Management's Q1 2025 Portfolio in Review
As of Q1 2025, Bayesian Capital Management held 1,036 positions worth $604M, down 26% from $817M the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Bayesian Capital Management withdrew a net $186M in Q1 2025, closing 470 positions and reducing 105 holdings. Its most notable exit was Amgen, an estimated $11.2M position sold in full.
By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 23% a quarter earlier, followed by Consumer Discretionary and Healthcare.
Against the trend, Bayesian Capital Management opened a new position in Advanced Micro Devices worth $9.96M.
- Bayesian Capital Management's largest Q1 2025 buy was Advanced Micro Devices: 96,900 shares worth $9.96M.
- Bayesian Capital Management added most to Cisco in Q1 2025, an estimated $12.4M increase.
- Bayesian Capital Management's biggest Q1 2025 reduction was Nike, cutting an estimated $15.4M.
- Bayesian Capital Management fully exited Amgen in Q1 2025, selling an estimated $11.2M.
- Bayesian Capital Management's ten largest holdings make up 14% of its $604M portfolio in Q1 2025.
- Bayesian Capital Management opened 389 new positions and closed 470 in Q1 2025.
- Bayesian Capital Management's portfolio value fell 26% quarter-over-quarter to $604M.
Based on Bayesian Capital Management's 13F filing for Q1 2025, filed 15 May 2025.